Neuroradiologists specialize in diagnosing neurological disorders through advanced imaging techniques. They interpret CT scans, MRIs, and angiograms to assess a wide range of conditions affecting the brain, spinal cord, and nervous system. Their expertise is crucial for identifying pathologies such as brain tumors, strokes, vascular malformations, and neurodegenerative diseases. Neuroradiologists use cutting-edge imaging modalities like functional MRI (fMRI) and positron emission tomography (PET) to analyze brain activity and metabolic functions, offering insights into brain function that help shape treatment plans. By collaborating with other healthcare providers such as neurologists, neurosurgeons, and oncologists, neuroradiologists play a vital role in determining appropriate therapies, including surgical intervention and targeted treatment strategies. In cases of acute neurological events like stroke, neuroradiologists can quickly pinpoint the site and type of the stroke, enabling rapid intervention that limits brain damage.
Furthermore, they assist in monitoring chronic neurological conditions like Alzheimer's disease and multiple sclerosis, tracking disease progression and informing management strategies. Neuroradiologists are increasingly involved in utilizing artificial intelligence tools to improve diagnostic accuracy and predict outcomes. Their ability to interpret complex images and data ensures that neurologists and other specialists have accurate and up-to-date information for making informed treatment decisions. Their work is instrumental in improving both diagnosis and treatment of neurological diseases, enhancing patient care and outcomes.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States